Stapel S O, Waanders-Lijster de Raadt J, van Toorenenbergen A W, de Groot H
Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
Allergy. 1998 Aug;53(8):769-77. doi: 10.1111/j.1398-9995.1998.tb03973.x.
To obtain more information on IgE cross-reactivity between bumblebee venom and honeybee venom, we tested sera from venom-sensitized patients for specific IgE against venoms from the European bumblebee (Bombus terrestris), the North American bumblebee (Megabombus pennsylvanicus), and the honeybee (Apis mellifera). RAST, RAST-inhibition, and immunoblotting experiments indicate that bumblebee venom and honeybee venom contain venom-specific IgE-binding epitopes. These results suggest that immunotherapy using honeybee venom may not be effective in all bumblebee venom-allergic patients. Our experiments also revealed differences in IgE binding for venom from European and American bumblebees.
为了获取更多关于大黄蜂毒液和蜜蜂毒液之间IgE交叉反应性的信息,我们检测了毒液致敏患者血清中针对欧洲大黄蜂(熊蜂)、北美大黄蜂和蜜蜂毒液的特异性IgE。放射免疫吸附试验(RAST)、RAST抑制试验和免疫印迹实验表明,大黄蜂毒液和蜜蜂毒液含有毒液特异性IgE结合表位。这些结果表明,使用蜜蜂毒液进行免疫治疗可能并非对所有大黄蜂毒液过敏患者都有效。我们的实验还揭示了欧洲大黄蜂和美洲大黄蜂毒液在IgE结合方面的差异。